Cargando…
FDG-PET Response Prediction in Pediatric Hodgkin’s Lymphoma: Impact of Metabolically Defined Tumor Volumes and Individualized SUV Measurements on the Positive Predictive Value
Background: In pediatric Hodgkin’s lymphoma (pHL) early response-to-therapy prediction is metabolically assessed by (18)F-FDG PET carrying an excellent negative predictive value (NPV) but an impaired positive predictive value (PPV). Aim of this study was to improve the PPV while keeping the optimal...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381259/ https://www.ncbi.nlm.nih.gov/pubmed/25635760 http://dx.doi.org/10.3390/cancers7010287 |
_version_ | 1782364419839229952 |
---|---|
author | Hussien, Amr Elsayed M. Furth, Christian Schönberger, Stefan Hundsdoerfer, Patrick Steffen, Ingo G. Amthauer, Holger Müller, Hans-Wilhelm Hautzel, Hubertus |
author_facet | Hussien, Amr Elsayed M. Furth, Christian Schönberger, Stefan Hundsdoerfer, Patrick Steffen, Ingo G. Amthauer, Holger Müller, Hans-Wilhelm Hautzel, Hubertus |
author_sort | Hussien, Amr Elsayed M. |
collection | PubMed |
description | Background: In pediatric Hodgkin’s lymphoma (pHL) early response-to-therapy prediction is metabolically assessed by (18)F-FDG PET carrying an excellent negative predictive value (NPV) but an impaired positive predictive value (PPV). Aim of this study was to improve the PPV while keeping the optimal NPV. A comparison of different PET data analyses was performed applying individualized standardized uptake values (SUV), PET-derived metabolic tumor volume (MTV) and the product of both parameters, termed total lesion glycolysis (TLG); Methods: One-hundred-eight PET datasets (PET1, n = 54; PET2, n = 54) of 54 children were analysed by visual and semi-quantitative means. SUVmax, SUVmean, MTV and TLG were obtained the results of both PETs and the relative change from PET1 to PET2 (Δ in %) were compared for their capability of identifying responders and non-responders using receiver operating characteristics (ROC)-curves. In consideration of individual variations in noise and contrasts levels all parameters were additionally obtained after threshold correction to lean body mass and background; Results: All semi-quantitative SUV estimates obtained at PET2 were significantly superior to the visual PET2 analysis. However, ΔSUVmax revealed the best results (area under the curve, 0.92; p < 0.001; sensitivity 100%; specificity 85.4%; PPV 46.2%; NPV 100%; accuracy, 87.0%) but was not significantly superior to SUVmax-estimation at PET2 and ΔTLGmax. Likewise, the lean body mass and background individualization of the datasets did not impove the results of the ROC analyses; Conclusions: Sophisticated semi-quantitative PET measures in early response assessment of pHL patients do not perform significantly better than the previously proposed ΔSUVmax. All analytical strategies failed to improve the impaired PPV to a clinically acceptable level while preserving the excellent NPV. |
format | Online Article Text |
id | pubmed-4381259 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-43812592015-05-04 FDG-PET Response Prediction in Pediatric Hodgkin’s Lymphoma: Impact of Metabolically Defined Tumor Volumes and Individualized SUV Measurements on the Positive Predictive Value Hussien, Amr Elsayed M. Furth, Christian Schönberger, Stefan Hundsdoerfer, Patrick Steffen, Ingo G. Amthauer, Holger Müller, Hans-Wilhelm Hautzel, Hubertus Cancers (Basel) Article Background: In pediatric Hodgkin’s lymphoma (pHL) early response-to-therapy prediction is metabolically assessed by (18)F-FDG PET carrying an excellent negative predictive value (NPV) but an impaired positive predictive value (PPV). Aim of this study was to improve the PPV while keeping the optimal NPV. A comparison of different PET data analyses was performed applying individualized standardized uptake values (SUV), PET-derived metabolic tumor volume (MTV) and the product of both parameters, termed total lesion glycolysis (TLG); Methods: One-hundred-eight PET datasets (PET1, n = 54; PET2, n = 54) of 54 children were analysed by visual and semi-quantitative means. SUVmax, SUVmean, MTV and TLG were obtained the results of both PETs and the relative change from PET1 to PET2 (Δ in %) were compared for their capability of identifying responders and non-responders using receiver operating characteristics (ROC)-curves. In consideration of individual variations in noise and contrasts levels all parameters were additionally obtained after threshold correction to lean body mass and background; Results: All semi-quantitative SUV estimates obtained at PET2 were significantly superior to the visual PET2 analysis. However, ΔSUVmax revealed the best results (area under the curve, 0.92; p < 0.001; sensitivity 100%; specificity 85.4%; PPV 46.2%; NPV 100%; accuracy, 87.0%) but was not significantly superior to SUVmax-estimation at PET2 and ΔTLGmax. Likewise, the lean body mass and background individualization of the datasets did not impove the results of the ROC analyses; Conclusions: Sophisticated semi-quantitative PET measures in early response assessment of pHL patients do not perform significantly better than the previously proposed ΔSUVmax. All analytical strategies failed to improve the impaired PPV to a clinically acceptable level while preserving the excellent NPV. MDPI 2015-01-28 /pmc/articles/PMC4381259/ /pubmed/25635760 http://dx.doi.org/10.3390/cancers7010287 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Hussien, Amr Elsayed M. Furth, Christian Schönberger, Stefan Hundsdoerfer, Patrick Steffen, Ingo G. Amthauer, Holger Müller, Hans-Wilhelm Hautzel, Hubertus FDG-PET Response Prediction in Pediatric Hodgkin’s Lymphoma: Impact of Metabolically Defined Tumor Volumes and Individualized SUV Measurements on the Positive Predictive Value |
title | FDG-PET Response Prediction in Pediatric Hodgkin’s Lymphoma: Impact of Metabolically Defined Tumor Volumes and Individualized SUV Measurements on the Positive Predictive Value |
title_full | FDG-PET Response Prediction in Pediatric Hodgkin’s Lymphoma: Impact of Metabolically Defined Tumor Volumes and Individualized SUV Measurements on the Positive Predictive Value |
title_fullStr | FDG-PET Response Prediction in Pediatric Hodgkin’s Lymphoma: Impact of Metabolically Defined Tumor Volumes and Individualized SUV Measurements on the Positive Predictive Value |
title_full_unstemmed | FDG-PET Response Prediction in Pediatric Hodgkin’s Lymphoma: Impact of Metabolically Defined Tumor Volumes and Individualized SUV Measurements on the Positive Predictive Value |
title_short | FDG-PET Response Prediction in Pediatric Hodgkin’s Lymphoma: Impact of Metabolically Defined Tumor Volumes and Individualized SUV Measurements on the Positive Predictive Value |
title_sort | fdg-pet response prediction in pediatric hodgkin’s lymphoma: impact of metabolically defined tumor volumes and individualized suv measurements on the positive predictive value |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381259/ https://www.ncbi.nlm.nih.gov/pubmed/25635760 http://dx.doi.org/10.3390/cancers7010287 |
work_keys_str_mv | AT hussienamrelsayedm fdgpetresponsepredictioninpediatrichodgkinslymphomaimpactofmetabolicallydefinedtumorvolumesandindividualizedsuvmeasurementsonthepositivepredictivevalue AT furthchristian fdgpetresponsepredictioninpediatrichodgkinslymphomaimpactofmetabolicallydefinedtumorvolumesandindividualizedsuvmeasurementsonthepositivepredictivevalue AT schonbergerstefan fdgpetresponsepredictioninpediatrichodgkinslymphomaimpactofmetabolicallydefinedtumorvolumesandindividualizedsuvmeasurementsonthepositivepredictivevalue AT hundsdoerferpatrick fdgpetresponsepredictioninpediatrichodgkinslymphomaimpactofmetabolicallydefinedtumorvolumesandindividualizedsuvmeasurementsonthepositivepredictivevalue AT steffeningog fdgpetresponsepredictioninpediatrichodgkinslymphomaimpactofmetabolicallydefinedtumorvolumesandindividualizedsuvmeasurementsonthepositivepredictivevalue AT amthauerholger fdgpetresponsepredictioninpediatrichodgkinslymphomaimpactofmetabolicallydefinedtumorvolumesandindividualizedsuvmeasurementsonthepositivepredictivevalue AT mullerhanswilhelm fdgpetresponsepredictioninpediatrichodgkinslymphomaimpactofmetabolicallydefinedtumorvolumesandindividualizedsuvmeasurementsonthepositivepredictivevalue AT hautzelhubertus fdgpetresponsepredictioninpediatrichodgkinslymphomaimpactofmetabolicallydefinedtumorvolumesandindividualizedsuvmeasurementsonthepositivepredictivevalue |